All lobbying filings

OCULUS STRATEGIES, LLC

OCULUS STRATEGIES, LLC filed a Q4 report for THE LIVINGSTON GROUP, LLC OBO INNOVATIVE VACCINE TECHNOLOGIES on January 8, 2026.

Lobbying for THE LIVINGSTON GROUP, LLC OBO INNOVATIVE VACCINE TECHNOLOGIES · Consulting/lobbying firm

All filings by OCULUS STRATEGIES, LLC · Everything THE LIVINGSTON GROUP, LLC OBO INNOVATIVE VACCINE TECHNOLOGIES has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 8, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

District of Columbia

Official filing document

Lobbyists on this filing 1

CHRISTOPHER CARON

Previously held: LD, Senior Policy Advisor, Deputy Chief of Staff, Rep. Tom Cole (OK-4)

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Defense

HR 3838, S 2296, FY2026 National Defense Authorization Act HR 4016, S 2572, FY2026 Defense Appropriations Act (Issues relating to the development of a vaccine delivery vehicle)

Bills named in this filing 2

H.R. 3838
Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 20…
H.R. 4016
Department of Defense Appropriations Act, 2026

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.